Paul Wachter, Director at Avalanche Biotechnologies, Inc. ([AAVL]), sold 1,192 shares at $36.11 ($43K) on 2015-06-01, disclosed to the SEC on 2015-06-02.
Scheduled sale ($43k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.11 | 982 | $35K | 82.1% |
| 2 | $36.81 | 210 | $8K | 17.9% |
| Total | $36.23 avg | 1,192 | $43K | 100% |
| Filing → |
| [AAVL] | SELL | 2015-06-10 | $46K | — | Filing → |
| [AAVL] | SELL | 2015-05-27 | $44K | — | Filing → |
| [AAVL] | SELL | 2015-05-19 | $42K | — | Filing → |